TOPDDRIVE
Live / Applied — Non-final action mailed (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 14 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99442152
- Mark type
- Stylized text
- Filed
- 14 Oct 2025
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceuticals and therapeutic agents for medical use
- Class 042 — Scientific and technological services: Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials
Owner
- Callio Operating Co, Inc., Seattle, WA, US
Prosecution history
- 20 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Mar 2026 — NON-FINAL ACTION E-MAILED
- 20 Mar 2026 — NON-FINAL ACTION WRITTEN
- 03 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Oct 2025 — NEW APPLICATION ENTERED